Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Obstructive airways disorder? 232 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 232 reports of Obstructive airways disorder have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.2% of all adverse event reports for RIVAROXABAN.

232
Reports of Obstructive airways disorder with RIVAROXABAN
0.2%
of all RIVAROXABAN reports
4
Deaths
45
Hospitalizations

How Dangerous Is Obstructive airways disorder From RIVAROXABAN?

Of the 232 reports, 4 (1.7%) resulted in death, 45 (19.4%) required hospitalization, and 6 (2.6%) were considered life-threatening.

Is Obstructive airways disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 232 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Obstructive airways disorder?

ALBUTEROL (4,195) TIOTROPIUM (2,634) PREDNISONE (2,480) BUDESONIDE\FORMOTEROL (2,210) MONTELUKAST (2,073) MEPOLIZUMAB (1,883) OMALIZUMAB (1,670) CICLESONIDE (1,403) FLUTICASONE\SALMETEROL (1,253) BUDESONIDE (1,214)

Which RIVAROXABAN Alternatives Have Lower Obstructive airways disorder Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Obstructive airways disorder Reports All Drugs Causing Obstructive airways disorder RIVAROXABAN Demographics